Scott A. Lang - 17 Jan 2025 Form 4/A - Amendment Insider Report for Anterix Inc. (ATEX)

Role
President and CEO, Director
Signature
s/ Gena L. Ashe, Attorney-in-Fact
Issuer symbol
ATEX
Transactions as of
17 Jan 2025
Net transactions value
$0
Form type
4/A - Amendment
Filing time
24 Jan 2025, 17:36:57 UTC
Date Of Original Report
22 Jan 2025
Previous filing
04 Oct 2024
Next filing
23 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATEX Stock Option (Right to Buy) Award $0 +191,326 $0.000000 191,326 17 Jan 2025 Common Stock 191,326 $30.99 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest and become exercisable in three annual installments with vesting commencing on January 17, 2025, subject to the Reporting Person's continuous services to the Issuer through each such vesting date.
F2 This amended Form 4 is being filed to correct the previously reported expiration date of the option shares.